We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Trius Therapeutics, Bayer Form Strategic Collaboration to Develop Torezolid Phosphate in Asia-Pacific and Emerging Markets
Trius Therapeutics, Bayer Form Strategic Collaboration to Develop Torezolid Phosphate in Asia-Pacific and Emerging Markets
July 27, 2011
Trius Therapeutics and Bayer announced they have signed an exclusive agreement to develop and commercialize Trius’ lead Phase III antibiotic, torezolid phosphate (torezolid), in China, Japan and all other countries in Asia, Africa, Latin America and the Middle East, excluding North and South Korea. MarketWatc
